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Introduction
Telomeres are specialized nucleoprotein structures that protect 
the ends of eukaryotic chromosomes from unscheduled DNA 
repair reactions and degradation (Chan and Blackburn, 2002;   
de Lange, 2005). In vertebrates, telomeres consist of TTAGGG 
repeats bound by a specialized multiprotein complex known as 
shelterin, which has fundamental roles in the regulation of telo-
mere length and protection (Liu et al., 2004; de Lange, 2005). 
Because of the intrinsic inability of the DNA replication ma-
chinery to copy the end of linear molecules, and to endogenous 
DNA end–degrading activities, telomeres become progressively 
shorter after every cell division cycle (Harley et al., 1990; 
Blasco, 2005).
Telomere repeats are generated by a ribonucleoprotein re-
verse transcriptase known as telomerase (Greider and Blackburn, 
1985); however, its abundance and activity in adult tissues is 
not  sufficient  to  compensate  for  the  progressive  telomere   
attrition that occurs with aging (Collins and Mitchell, 2002).   
In humans, several studies have described an inverse correlation 
between telomere length and age in a variety of tissues and   
between telomere length and certain age-associated diseases 
(Cawthon et al., 2003; Panossian et al., 2003; Ogami et al., 
2004; Canela et al., 2007). Also, factors that may decrease lon-
gevity, such as psychological stress or obesity, are proposed to 
negatively impact on telomerase activity and telomere length 
(Epel et al., 2004; Valdes et al., 2005). In the absence of telomerase, 
telomeres  can  be  maintained  by  a  recombination-dependent 
mechanism (Dunham et al., 2000) known as alternative length-
ening of telomeres (ALT; McEachern et al., 2000), which in-
volves DNA repair proteins such as the Mre11–Rad50–Nbs1 
and SMC5–SMC6–MMS21 complexes (Jiang et al., 2005; Potts 
and Yu, 2007).
Silent information regulator 2 (Sir2) family of proteins is a 
group of NAD
+-dependent deacetylases/ADP-ribosyltransferases 
(type III histone deacetylase) initially discovered in yeast and 
are identified as key regulators of health span and lifespan in 
yeast and other organisms (Haigis and Guarente, 2006). Yeast 
Sir2 functions encompass (a) repression of gene expression at 
the silent mating type loci HML and HMR (Klar et al., 1979; 
Rine et al., 1979) (b) to suppress recombination at the ribosomal 
Y
east Sir2 deacetylase is a component of the silent 
information regulator (SIR) complex encompassing 
Sir2/Sir3/Sir4. Sir2 is recruited to telomeres through 
Rap1, and this complex spreads into subtelomeric DNA 
via histone deacetylation. However, potential functions at 
telomeres for SIRT1, the mammalian orthologue of yeast 
Sir2, are less clear. We studied both loss of function (SIRT1 
deficient) and gain of function (SIRT1
super) mouse models. 
Our results indicate that SIRT1 is a positive regulator of 
telomere length in vivo and attenuates telomere shortening 
associated with aging, an effect dependent on telomerase 
activity. Using chromatin immunoprecipitation assays, we 
find that SIRT1 interacts with telomeric repeats in vivo.   
In addition, SIRT1 overexpression increases homologous 
recombination throughout the entire genome, including 
telomeres, centromeres, and chromosome arms. These 
findings link SIRT1 to telomere biology and global DNA 
repair and provide new mechanistic explanations for the 
known functions of SIRT1 in protection from DNA damage 
and some age-associated pathologies.
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(Broccoli et al., 1997) and mediate the association of human 
Rap1 to telomeres (de Lange, 2009; Takai et al., 2010). A poten-
tial role of SIRT1 at mammalian telomeres is, therefore, less 
clear. More recently, SIRT1 depletion has been shown to cause 
telomere dysfunction (El Ramy et al., 2009). Interestingly, acti-
vation of SIRT1 with resveratrol produces an increase in extra-
chromosomal telomeric DNA and in colocalization of telomeric 
TRF1 with WRN helicase and BRCA1 in cells that elongate 
telomeres using ALT (Rusin et al., 2009).
In this study, we set to understand a potential role of mam-
malian SIRT1 in telomere biology by studying both loss of 
function (SIRT1-deficient mice) and gain of function (SIRT1
super 
mice) mouse models (Cheng et al., 2003; Pfluger et al., 2008). 
Our results indicate that mammalian SIRT1 interacts with the 
mouse telomeric repeats and acts as a positive regulator of telo-
mere length in vivo by significantly attenuating telomere short-
ening associated with mouse aging. In addition, we find an 
important role of SIRT1 in promoting recombination at differ-
ent  chromosomal  regions,  including  telomeres,  centromeres, 
and chromosome arms. These findings link SIRT1 to telomeres 
and provide new mechanistic explanations for the known roles 
of augmented SIRT1 expression in protection from DNA dam-
age and in prevention from some age-associated pathologies.
Results
SIRT1 levels influence telomere length in 
mouse embryonic fibroblasts (MEFs)
To address a potential role of SIRT1 in telomere length mainte-
nance, we performed both telomere restriction fragment (TRF) 
analysis and metaphase telomere quantitative FISH (Q-FISH) 
on MEFs derived from either SIRT1-deficient or SIRT1
super mice 
and their corresponding wild-type controls. We have previously 
shown that SIRT1
super MEFs have a threefold increase in SIRT1 
expression compared with wild-type controls (Pfluger et al., 
2008; Herranz et al., 2010). SIRT1
super MEFs showed a modest 
but significant increase in mean telomere length compared with 
wild-type MEFs both by TRF and Q-FISH analyses (Fig. 1 A; 
and Fig. S1, A and B). Q-FISH analysis further indicated that 
increased telomere length in SIRT1
super MEFs is accompanied 
by a significant decrease of signal-free ends (SFEs) or chromo-
some ends with undetectable telomere signals and by a decrease 
in the proportion of short telomeres (<30 kb) and an increase in 
the proportion of long telomeres (>80 kb; Fig. 1 B). These re-
sults indicate that elevated SIRT1 expression leads to improved 
telomere length maintenance in cultured primary MEFs. In turn, 
SIRT1-deficient MEFs showed significantly shorter telomeres 
compared with wild-type MEFs as determined both by Q-FISH 
and TRF analyses (Fig. 1 C; and Fig. S1, A and B). Shorter mean 
telomere length in SIRT1
/ MEFs was accompanied by a sig-
nificant increase in the proportion of short telomeres and a de-
crease in the proportion of long telomeres (Fig. 1 D). To confirm 
whether the observed effects were specifically associated with 
the SIRT1 protein, wild-type and SIRT1
/ MEFs were trans-
fected with a SIRT1-coding plasmid (for SIRT1 expression   
levels see Fig. S2, A and B) and evaluated its effect on telomere 
length by Q-FISH analysis. Both SIRT1
+/+ and SIRT1
/ MEFs 
DNA locus, thus preventing generation of toxic ribosomal DNA 
circles (Sinclair and Guarente, 1997), and (c) to maintain the 
heterochromatic state of telomeres (Bedalov et al., 2001; Xu   
et al., 2007).
Mammals have seven (SIRT1–7) known sirtuins, of which 
SIRT1 is the closest and best-characterized mammalian ortho-
logue of yeast Sir2 (Brachmann et al., 1995; Frye, 1999). SIRT1 
deacetylase activity has been involved in chromatin remodel-
ing, gene silencing, and the DNA damage response (Kim and 
Um, 2008; Cantó and Auwerx, 2009; Milner, 2009). Further-
more, mounting evidence has connected SIRT1 to stress re-
sponses in mammals (Abdelmohsen et al., 2007; Wang et al., 
2007; Westerheide et al., 2009). In particular, SIRT1 is recruited 
to the chromatin upon different DNA damage insults, where it   
favors efficient repair of double-strand breaks (DSBs) by homol-
ogous recombination (Oberdoerffer et al., 2008). In this re-
gard, SIRT1 physically interacts and deacetylates the WRN 
helicase (Vaitiekunaite et al., 2007; Kahyo et al., 2008; Li et al., 
2008; Law et al., 2009), in this manner modulating homologous 
recombination–dependent DSB DNA repair (Uhl et al., 2010). 
SIRT1 also targets Nbs1, a regulatory subunit of the Mre11–
Rad50–Nbs1 complex (Yuan and Seto, 2007; Yuan et al., 2007). 
SIRT1-mediated Nbs1 deacetylation specifically inhibits Nbs1 
phosphorylation  and  modulates  its  activity  in  intra–S  phase 
checkpoint induction (Kastan and Lim, 2000; Lim et al., 2000). 
Together, these findings suggest a potential role of SIRT1 in the 
regulation of DNA repair pathways.
Much  attention  has  recently  been  given  to  the  role  of 
SIRT1 in metabolic tissues, such as the liver, skeletal muscle, 
and adipose tissues, where it deacetylates a range of substrates, 
including key metabolic regulators PGC1, UCP2, NFB, and 
Foxo proteins, which in turn have pronounced effects on glu-
cose homeostasis, insulin secretion, and lipid homeostasis   
(Liang et al., 2009). Among other metabolic effects, SIRT1 is 
known to participate in the activation of gluconeogenic genes 
and to increase both hepatic glucose output during calorie   
restriction (CR) and reverse cholesterol transport and fat mobi-
lization in white adipose tissue (Brooks and Gu, 2009). We have 
previously generated mice that contain additional copies of the 
SIRT1 gene under the control of its natural regulatory elements 
and that express threefold SIRT1 in a homogenous and systemic 
manner across all tissues, known as SIRT1
super mice (Pfluger   
et al., 2008). These mice are protected from physiological   
damage produced by exposure to a high fat diet. In addition,   
SIRT1
super mice are protected from DNA damage and liver   
carcinogenesis and show decreased signs of aging, including 
decreased expression of the aging-associated gene p16Ink4a 
(Herranz et al., 2010).
In yeast, Sir2, together with Sir3 and Sir4, is recruited to 
telomeres through Rap1, and this complex spreads along sub-
telomeric sequences enforcing transcriptional silencing (Perrod 
and Gasser, 2003; Bühler and Gasser, 2009). A Rap1-like pro-
tein is conserved in both human and fission yeast (Konig et al., 
1996; Li et al., 2000; Park et al., 2002). However, human Rap1 
lacks the DNA-interacting Myb domain and does not bind telo-
meric repeats. Other Myb box–related-containing proteins in 
mammals such as TRF2 bind directly to telomeric DNA repeats 1301 Beneficial effects of increasing SIRT1 on telomere maintenance • Palacios et al.
Figure 1.  Increased SIRT1 expression leads to longer telomeres, whereas SIRT1 deficiency results in telomere shortening in primary MEFs. (A) Telomere 
length frequency distribution (Q-FISH) in metaphase spreads from SIRT1
+/+ and SIRT1
super primary (passage 2) MEFs. (B) Telomere length frequency dis-
tribution (Q-FISH) in metaphase spreads from SIRT1
+/+ and SIRT1
/ primary (passage 2) MEFs. (C and D) Mean telomere length, percentage of SFEs, 
percentage of short telomeres (<30 kb), and percentage of long telomeres (>80 kb) in primary MEFs from the indicated genotypes. (E) Telomere length 
frequency distribution (Q-FISH) in metaphase spreads from SIRT1
+/+ and SIRT1
/ primary (passage 2) MEFs transfected with pHA-SIRT1 (pCruz-HA-SIRT1) and 
pHA (pCruz-HA) plasmids. (F) Mean telomere length, percentage of SFEs, percentage of short telomeres (<30 kb), and percentage of long telomeres 
(>80 kb) in primary MEFs from the indicated genotypes. SEM, number of MEFs, and the number of telomeres used for analysis are shown for each 
genotype. Student’s t test was used in the case of mean telomere intensity; otherwise, the Fisher exact test was used for statistical calculations. P-values 
are indicated.JCB • VOLUME 191 • NUMBER 7 • 2010   1302
maintenance during aging. This finding is in agreement with 
the fact that SIRT1
super mice are protected from some age- 
related diseases such as hepatic steatosis, insulin resistance, 
liver cancer associated with metabolic syndrome, and osteo-
porosis (Pfluger et al., 2008; Herranz et al., 2010).
SIRT1 effects on telomere length are 
largely dependent on telomerase activity
In most eukaryotes, telomeres are maintained by telomerase, a 
reverse transcription that adds telomeric repeats de novo after 
every cell division cycle, in this manner counteracting for the 
incomplete DNA replication of telomeres caused by the end repli-
cation problem (Collins and Mitchell, 2002; Chan and Blackburn, 
2004). To address the mechanisms by which cells and tissues 
from  SIRT1-overexpressing  mice  show  improved  telomere 
length maintenance, we first set to measure telomerase activity 
by using the in vitro TRAP assay (see Materials and methods). 
As shown in Fig. 3 (A and B), in vitro telomerase activity was 
similar in wild-type and SIRT1
super MEFs, indicating that in-
creased SIRT1 expression does not significantly affect telomer-
ase in vitro activity.
Next, we addressed whether longer telomeres in SIRT1
super 
MEFs were dependent on the presence of a proficient telomer-
ase complex. To this end, we generated SIRT1
super mice simulta-
neously deficient for the essential telomerase RNA component 







+/+,  and 
SIRT1
+/+;Terc
/ MEFs. Southern blot–based TRF analysis 
confirmed longer telomeres in SIRT1
super MEFs compared with 
wild-type controls in a telomerase-proficient Terc
+/+ background 
(Fig. 3, C and D). Terc deficiency resulted in significant telo-
mere  shortening  in  both  the  SIRT1
+/+  and  SIRT1
super  back-
grounds,  indicating  similar  rates  of  telomere  erosion  in  the 
absence of telomerase activity. Further analysis using the more-
sensitive Q-FISH technique confirmed a significant increase in 





/ MEFs (Fig. 3, E and F), 
again  indicating  that  telomerase  deficiency  causes  similar   
rates  of  telomere  erosion  independently  of  SIRT1  amounts.   
Q-FISH analysis also indicated that SIRT1
super;Terc
/ MEFs 
showed a similar mean telomere length to that of SIRT1
+/+; 
Terc
/  controls,  again  suggesting  that  longer  telomeres  in 
SIRT1
super MEFs are dependent on the presence of telomerase 
activity. Interestingly, the percentage of SFEs and cells with 
short telomeres was significantly increased in SIRT1
super;Terc
/ 
MEFs  compared  with  SIRT1
+/+;Terc
/  controls,  suggesting 
that augmented SIRT1 expression may accelerate telomere   
loss when in the absence of telomerase activity. In line with   












/ mice have a significant decreased 
survival when compared with SIRT1
+/+;Terc
/ mice (Fig. S5), 
which further suggests a negative effect of increased SIRT1   
expression in the context of telomerase deficiency. Together, 
these results suggest that maintenance of longer telomeres   
in SIRT1
super MEFs requires the presence of a proficient telo-
merase complex.
transfected with the SIRT1 plasmid showed an increase in telo-
mere length compared with cells transfected with the control 
plasmid (Fig. 1 E). In all cases, increased telomere length was 
accompanied by a significant decrease in the proportion of short 
telomeres (<30 kb) and an increase in the proportion of long 
telomeres (>80 kb); an almost significant decrease in SFEs was 
also observed in the SIRT1-tranfected SIRT1
/ MEFs (Fig. 1 F). 
Together, the analyses of gain of function and loss of function 
MEFs for SIRT1 strongly suggest a role for the mammalian   
homologue of yeast Sir2 in telomere length maintenance in vivo.
Increased SIRT1 expression attenuates 
telomere erosion with age in adult tissues
Given the presence of longer telomeres in SIRT1
super MEFs, we 
wondered whether increased SIRT1 expression also improved 
telomere length maintenance in the context of adult mouse tis-
sues. We have recently shown that SIRT1 overexpression in 
mice has significant beneficial effects on liver function (Pfluger 
et al., 2008; Herranz et al., 2010). Thus, we set to measure 
telomere length in liver sections from age- and sex-matched   
SIRT1
super  and  SIRT
+/+  littermates  using  telomere  Q-FISH. 
Telomere length analysis of the hepatic parenchyma of 2-yr-old 
SIRT1
super mice showed a significant increase in mean telomere 
length compared with wild-type controls (Fig. 2 A). Longer 
telomeres in the liver of old SIRT1
super mice were accompanied 
by a significant increase in the proportion of very long telo-
meres (>80 arbitrary units of fluorescence [auf]) and a signifi-
cant reduction in the proportion of short telomeres (<60 auf; 
Fig. 2 B). Furthermore, supporting a role for SIRT1 in telo-
mere  maintenance,  liver  sections  from  2-yr-old  SIRT1
/ 
mice showed significantly shorter telomeres than those of age-
matched SIRT1
+/+ controls in the hepatic parenchyma (Fig. 2 D).   
In concordance with the results in MEFs, shorter mean telo-
mere length was accompanied by a significant increase in the 
proportion of very short telomeres (<100 auf) and by a signifi-
cant decrease in the proportion of very long telomeres (>120 
auf; Fig. 2 E). The same analysis was conducted in kidney sec-
tions (both in renal glomeruli and tubules) from 2-mo- and   
2-yr-old  mice.  Mean  telomere  length  decreased  both  in  the 
glomeruli  and  tubules  from  2-yr-old  mice  compared  with   
2-mo-old wild-type mice, which is in agreement with our pre-
vious  observations  showing  telomere  shortening  associated 
with old age in many mouse tissues (Flores et al., 2008). Nota-
bly, this trend is not observed in SIRT1
super mice, where 2-yr-
old mice showed longer telomeres compared with 2-mo-old 
mice (Fig. 2 G). Longer telomeres in the kidney of SIRT1
super 
mice were accompanied by an increase in the proportion of 
cells with long telomeres and a reduction in the proportion of 
cells with short telomeres in SIRT1
super mice in both age groups 
(Fig. 2, G and H). In particular, although wild-type kidneys 
showed an increase in the percentage of cells with short telo-
meres in 2-yr-old mice compared with 2-mo-old mice, which 
was concomitant with a decrease in the percentage of cells with 
very long telomeres (Fig. 2 H), these changes were not ob-
served in kidneys from SIRT1
super mice (Fig. 2 H). Together, 
these results suggest that a moderate increase in SIRT1 ex-
pression (threefold) has beneficial effects on telomere length 1303 Beneficial effects of increasing SIRT1 on telomere maintenance • Palacios et al.
Figure 2.  Increased SIRT1 expression improves telomere length maintenance with increasing age in SIRT1
super mice. (A and D, left) Telomere fluorescence 
frequency distribution as determined by Q-FISH on liver sections from mice of the indicated genotypes. (C and F) Representative images of telomere Q-FISH 
on liver sections from SIRT1
super and SIRT1
+/+ mice, where DAPI nuclear staining is shown in blue and telomere signal in red. (B) Mean telomere length in 
auf, percentage of short telomeres (<60 auf), and percentage of long telomeres (>80 auf) are shown. (E) Mean telomere length in auf, percentage of short 
telomeres (<100 auf), and percentage of long telomeres (>120 auf) are shown. (G) Telomere fluorescence frequency distribution (Q-FISH) of glomeruli 
and tubules in kidney sections from mice of the indicated age and genotype. (H) Mean telomere fluorescence, percentage of short telomeres (<100 auf), 
and percentage of long telomeres (>120 auf) are shown. Note that telomere fluorescence decreases with age in kidney glomeruli and tubules indicative 
of telomere shortening, whereas this shortening does not occur in SIRT1
super mice. SEM, the number of animals, and telomere signals used for the analysis 
are shown for each genotype. Student’s t test was used in the case of the mean telomere intensity; otherwise, the Fisher exact test was used for statistical 
calculations. P-values are indicated. Bars, 100 µm.JCB • VOLUME 191 • NUMBER 7 • 2010   1304
Figure 3.  SIRT1 effects on telomere length are largely dependent on a proficient telomerase complex. (A) Telomerase in vitro TRAP activity is similar in 
SIRT1
super and wild-type primary (passage 2) MEFs (n = 3). A representative TRAP gel is shown for illustrative purposes. (B) Quantification of telomerase 
TRAP activity is expressed in arbitrary units (au). Extracts were pretreated (+) or not () with RNase as a negative control. n = number of TRAP assays 
from a total of three MEF cultures per genotype. (C) TRF analysis of primary (passage 2) MEFs of the indicated genotypes (n = 3). Note accumulation of 
small-size telomere fragments in the Terc-deficient genotypes independently of SIRT1 status. (D) Mean telomere length in MEFs of the indicated genotypes 
as determined by TRF is shown. SEM and number of MEFs used for the analysis are indicated for each genotype. The Student’s t test was used for statisti-
cal calculations, and p-values are indicated. (E) Telomere length frequency distribution (Q-FISH) in metaphase spreads from primary MEFs of the indicated 
genotypes. All MEFs used are littermates. (F) Mean telomere length, percentage of SFEs, percentage of short telomeres (<20 kb), and percentage of long 
telomeres (>60 kb) are shown. SEM and number of telomeres used for the analysis are shown for each genotype. Student’s t test was used in the case of 
mean telomere length and TRAP assay; otherwise, the Fisher exact test was used for statistical calculations. P-values are indicated. Note a similar increase 
in SFEs and in the percentage of short telomeres in wild-type and SIRT1
super MEFs in the context of telomerase deficiency (Terc
/). Note that mean telomere 
length values are not directly comparable with those shown in Fig. 1 because of the fact that they correspond to independent experiments not performed 
in parallel and fluorescence intensity may vary between different experiments.1305 Beneficial effects of increasing SIRT1 on telomere maintenance • Palacios et al.
chromosome  orientation  FISH  (CO-FISH)  on SIRT1
super  and 
SIRT1
/ MEFs and their respective wild-type controls, which 
measures the frequency of sister chromatid exchanges (SCEs) 
specifically at the telomeric repeats (T-SCE; Bailey et al., 1996). 
Strikingly, MEFs overexpressing SIRT1 showed a significant 
increase in the frequency of SCEs at telomeres compared with 
Increased SIRT1 expression augments 
homologous recombination at telomeres, 
centromeres, and chromosome arms
Telomere maintenance by ALT relies on recombination events 
between telomeric sequences. To address whether SIRT1 in-
fluences telomere recombination frequencies, we performed   
Figure 4.  SIRT1-increased expression results in higher 
recombination frequencies at telomeres, centromeres, 
and chromosome arms. (A) Representative telomere CO- 
FISH images of chromosomes from primary (passage 2)   
MEFs  of  the  indicated  genotypes  showing  increased 
recombination  events  at  telomeres  (T-SCE)  in  SIRT1
super 
MEFs. Lagging strand is shown in red, leading strand 
in green, and DAPI staining in blue. Yellow arrowheads   
indicate occurrence of T-SCE. (B) Quantification of sister   
telomere  recombination  events  (T-SCE)  expressed  as   
a fold increase with respect to wild-type MEFs (set to 1).   
(C) Representative centromere CO-FISH images of chromo-
somes from primary (passage 2) MEFs showing increased 
recombination at centromeres (C-SCE) in SIRT1
super MEFs. 
Lagging strand is shown in red, leading strand in green, 
and DAPI staining in blue. Yellow arrowheads indicate 
occurrence  of  C-SCE.  (D)  Quantification  of  the  centro-
mere recombination events (C-SCE) expressed as a fold 
increased of wild-type MEFs (set to 1). SEM, number of re-
combination events, and total number of analyzed MEFs 
and chromosomes are indicated. Fisher exact test was 
used for statistical analysis, and p-values are indicated. 
(E) Representative images of chromosomes from primary 
(passage  2)  MEFs  showing  increased  SCE  at  chromo-
some arms in SIRT1
super MEFs. Red arrowheads indicate 
SCE events. (F) Quantification of global recombination 
events (SCE) expressed as a fold increased of wild-type 
MEFs (set to 1). SEM, number of recombination events, 
and total number of analyzed MEFs and chromosomes 
are indicated. Fisher exact test was used for statistical 
analysis, and p-values are indicated. Bars, 1 µm.JCB • VOLUME 191 • NUMBER 7 • 2010   1306
related to increased telomere fragility (Muñoz et al., 2005; Blanco 
et al., 2007; Martínez et al., 2009; Sfeir et al., 2009). In particular, 
MTS have been proposed to result from replication fork stalling 
and increased breakage at telomeres, as they are increased by 
aphidicolin treatment, which is known to inhibit DNA synthesis 
and induce DNA breaks at chromosome-fragile sites (Durkin and 
Glover, 2007). In concordance with this notion, MTS were in-
creased in wild-type MEFs treated with aphidicolin and further 
increased in SIRT1-deficient MEFs (Fig. 6, A, C, and D), sug-
gesting that SIRT1-deficient cells are more prone to replication 
fork stalling and breakage. However, chromosome end-to-end 
fusions were not increased by SIRT1 deficiency, indicating that 
SIRT1 is not essential for telomere capping (Fig. 6 B). Impor-
tantly, SIRT1 overexpression in SIRT1
super MEFs did not increase 
MTS or any other type of telomere aberration (Fig. 6, A–D), 
again supporting the notion that increased SIRT1 expression has 
no deleterious effects on telomere function and integrity. Absence 
of TIFs and telomere aberrations (fusions and MTS) associated 
with SIRT1-increased expression is in agreement with normal 
telomere capping in these cells. Notably, decreased SFE associ-
ated with SIRT1 overexpression (Figs. 1 and 3) may reflect 
longer telomeres in these cells, as not all SFEs (telomeres under 
the Q-FISH detection level) correspond to TIFs.
SIRT1-mediated deacetylation of telomeric 
and pericentromeric regions
Telomeric chromatin is composed of TTAGGG repeats bound 
by shelterin. Mammalian telomeres also contain arrays of nucleo-
somes enriched in histone heterochromatic marks (Blasco, 
2007), and they are associated with long, noncoding telomeric 
RNAs or TERRA (Azzalin et al., 2007; Schoeftner and Blasco, 
2008). Telomeric and subtelomeric chromatin are characterized   
by a high density of H3K9me3 and H4K20me3 histone trimethyl-
ation marks and by HP1 binding (García-Cao et al., 2004; 
their wild-type controls (Fig. 4, A and B), suggesting that in-
creased SIRT1 expression favors telomeric recombination.   
Interestingly, SIRT1 abrogation in MEFs did not significantly 
affect T-SCEs frequencies compared with wild-type controls. 
Together, these results suggest that SIRT1 gain of function sig-
nificantly augments homologous recombination between telo-
meric sequences but that SIRT1 activity is not essential to 
mediate these events. Notably, increased telomere recombi-
nation may be responsible for accelerated telomere loss of   
SIRT1
super MEFs compared with controls when a telomerase-
deficient background is present (Fig. 3 E). In particular, homol-
ogous recombination at telomeric repeats can occur at multiple 
points, leading to an unequal exchange of telomeric repeats, 
thus generating chromosomes with unequal telomere lengths 
including short and long telomeres (Bailey et al., 2004; Blagoev 
and Goodwin, 2008).
Next, we set to determine whether the effect of increased 
SIRT1 expression on homologous recombination was specific 
of telomeric regions or reflected a global role of SIRT1 in favor-
ing homologous recombination throughout the genome. To this 
end, we measured SCE events both at centromeric repeats   
(C-SCE;  Jaco  et  al.,  2008)  and  chromosome  arms  (SCE;  see   
Materials and methods). As shown in Fig. 4 (C and D), SIRT1
super 
MEFs showed increased frequencies of C-SCE, whereas SIRT1
/ 
MEFs showed normal frequencies compared with wild-type MEFs. 
SCE frequencies at chromosome arms were also significantly 
elevated in SIRT1
super MEFs compared with wild-type controls or 
SIRT1
/ MEFs, confirming an impact of increased SIRT1 expres-
sion on global recombination frequencies (Fig. 4, E and F).
SIRT1 deficiency triggers a DNA damage 
response at chromosome ends
As SIRT1 deficiency in MEFs results in shorter mean telomere 
length compared with wild-type MEFs and SIRT1 overexpres-
sion significantly increases SCE frequencies, we wondered 
whether SIRT1 abrogation or SIRT1 overexpression could lead 
to increased damage at telomeres. -H2AX foci have been pre-
viously shown to indicate the presence of DNA DSBs, includ-
ing  those  associated  with  critically  short  and  dysfunctional 
telomeres, also known as TIFs (d’Adda di Fagagna et al., 2003; 
Takai et al., 2003). SIRT1 overexpression in SIRT1
super MEFs 
did not significantly increase the occurrence of TIFs when com-
pared with their respective wild-type controls (Fig. 5, A and B). 
In contrast, SIRT1-deficient MEFs showed a significant increase 
in the proportion of cells with more than three TIFs compared 
with the wild-type controls (Fig. 5, A and B). These results sug-
gest that although increased SIRT1 expression has no deleteri-
ous effects on telomere function, SIRT1 deficiency results in 
significant telomere dysfunction.
SIRT1 prevents telomere fragility
To further explore a putative role of SIRT1 in telomere protec-
tion, we performed metaphase Q-FISH analysis with a telomeric 
probe on SIRT1
super and SIRT1
/ MEFs and their respective 
wild-type controls. SIRT1
/ MEFs showed a significantly in-
creased proportion of chromosome ends with multiple telomeric 
signals (MTS) (Fig. 6, A, C, and D), a type of aberration recently 
Figure 5.  SIRT1 deficiency leads to increased telomere damage in pri-
mary MEFs. (A) Representative images of TRF1 (red) and -H2AX (green) 
immunofluorescence.  Colocalization  events  indicate  occurrence  of  TIFs 
(yellow arrowheads). (B) Quantification of cells with more than three TIFs 
in primary MEFs of the indicated genotypes. Number of TIF-positive, total 
cells, and independent MEFs per genotype are shown. Fisher exact test 
was used for statistical analysis, and p-values are indicated. Error bars 
represent SEM. Bars, 10 µm.1307 Beneficial effects of increasing SIRT1 on telomere maintenance • Palacios et al.
and by H3 and H4 abundance at these regions (Fig. 7). We did 
not detect significant changes in the density of the TRF1 shelterin 
protein at telomeres (Fig. 7, A, B, E, and F). As negative control, 
TRF1 was not bound to pericentromeric chromatin (Fig. 7,   
C, D, G, and H). Together, these results suggest that SIRT1 
levels negatively modulate histone acetylation at telomeric 
chromatin, concomitantly increasing heterochromatic marks 
such as H3K9me3 and H4K20me3.
We next analyzed the impact of both SIRT1 deficiency and 
SIRT1-increased expression on global DNA methylation mea-
sured as the proportion of methylated CpG at the B1 SINE   
repeats, and we determined DNA methylation of subtelomeric 
sequences located at chromosomes 1 and 2 by bisulphite se-
quencing (see Materials and methods). As shown in Fig. S3 and 
Fig. S4, we did not find significant differences in DNA methylation 
levels at these regions between SIRT1
super, SIRT1
/, and their 
respective wild-type controls.
SIRT1 specifically binds to telomeric 
repeats in vivo in induced pluripotent stem 
(iPS) cells
To address whether the effects of SIRT1 on telomere length, 
telomere heterochromatin, and telomere integrity (fragility and 
Gonzalo et al., 2005). In addition, subtelomeric DNA repeats 
are heavily methylated (Blasco, 2007).
Given that SIRT1 has histone deacetylase activity, we first 
set to determine the abundance of different histone marks at 
telomeric and pericentromeric chromatin in SIRT1
super MEFs 
and their corresponding wild-type controls by using chromatin 
immunoprecipitation (ChIP) followed by detection of telomeric 
repeats (see Materials and methods). Interestingly, we observed 
a significant reduction in the density of H3K9Ac at telomeres 
when SIRT1 deacetylase was overexpressed (Fig. 7, A and B). 
These results are in line with a role of SIRT1 in regulation of 
acetylation levels at mammalian telomeres. Interestingly, when 
a similar analysis was performed on pericentromeric chromatin, 
we also observed decreased H3K9Ac, which almost reached 
significance, and a significant increase in H4K20me3 trimethyl-
ation (Fig. 7, C and D), which is suggestive of induction of a more 
heterochromatic state. In line with this, when we performed a sim-
ilar ChIP analysis on SIRT1
/ MEFs, we observed that absence 
of SIRT1 results in a significant decrease of the heterochro-
matic marks H3K9me3 and HP1- at telomeric repeats (Fig. 7,   
E and F), a trend that did not reach significance in the case of 
pericentomeric repeats (Fig. 7, G and H). ChIP values were cor-
rected both by the respective telomere and centromere inputs 
Figure 6.  SIRT1 deficiency leads to increased MTS related to telomere fragility. (A) Quantification of MTS in primary (passage 2) MEFs of the indicated 
genotypes. (B) Quantification of end to end fusions in MEFs of the indicated genotypes. (C) Quantification of fold increase in MTS in metaphases of the 
indicated genotypes with and without treatment with aphidicolin compared with wild-type MEFs. Cells were treated with aphidicolin when indicated. SEM 
and the number of chromosomes, metaphases, and telomeres used for the analysis are shown for each genotype. The Fisher exact test was used for statisti-
cal calculations, and p-values are indicated. (D) Representative images showing increased MTS in SIRT1-deficient MEFs are shown. Telomere lagging strand 
is shown in red, leading strand in green, and DAPI staining in blue. Yellow arrowheads indicate the MTS. Bars, 1 µm.JCB • VOLUME 191 • NUMBER 7 • 2010   1308
Sir2, also plays an important role in longevity and resistance   
to age-associated diseases in higher organisms by increasing 
health span (Chen et al., 2005; Bordone et al., 2007; Boily et al., 
2008; Campisi and Yaswen, 2009; Cantó and Auwerx, 2009; 
Cohen et al., 2009; Saunders and Verdin, 2009; Herranz et al., 
2010). However, the molecular mechanisms by which SIRT1 
impacts on CR, lifespan, and health span are still largely un-
known (Wood et al., 2004).
Telomere shortening is associated with organismal aging 
and increased telomeric damage, proposed to be causative of 
aging-associated pathologies in humans (Blasco et al., 1997; 
Flores et al., 2005; Ornish et al., 2008; Martínez et al., 2009). 
Generation of the first knockout mice for the telomerase RNA 
component (Blasco et al., 1997) showed a conserved role for 
telomerase as the main activity responsible for maintaining 
telomere length in mammals and uncovered its importance in 
tissue renewal and lifespan and showed that short telomeres 
could cause multiple defects associated with decreased adult 
stem cell functionality. Remarkably, telomerase-deficient mice 
from the first generation already show a decreased median and 
maximum life span, indicating that telomere length and telo-
merase are rate limiting for mouse longevity in spite of mice born 
with very long telomeres (García-Cao et al., 2004). This is in 
line with recent findings showing that mouse telomeres suffer a 
dramatic shortening when comparing old (2-yr old) with young 
individuals (2-mo old; Flores et al., 2008). Furthermore, de-
creasing the rate of telomere erosion by forcing telomerase ex-
pression in adult tissues significantly delays aging and extends 
recombination) were mediated by binding of SIRT1 to telo-
meres in vivo, we performed ChIP analysis of telomeric and 
centromeric repeats with SIRT1 antibodies. We did not detect 
specific SIRT1 binding to telomeric chromatin in MEFs. To rule 
out this apparent lack of SIRT1 binding to telomeric repeats as 
the result of a transient association, we set to perform SIRT1 
ChIP analysis in cells with very long telomeres such as those of 
pluripotent stem cells (Flores et al., 2008; Marion et al., 2009b). 
Interestingly, stem cells express high levels of SIRT1 compared 
with differentiated tissues (McBurney et al., 2003; Kuzmichev 
et al., 2005; Saunders et al., 2010), and SIRT1 has been shown 
to regulate neural and glial specification of neural precursors 
(Prozorovski et al., 2008), differentiation of skeletal myoblasts 
(Fulco et al., 2008), and to inhibit spermatogenesis (Coussens   
et al., 2008). To this end, we produced iPS from SIRT1
+/+ and 
SIRT1
/ MEFs and evaluated SIRT1 binding to telomere re-
peats in vivo. As shown by ChIP analysis, SIRT1 specifically 
binds to telomeric repeats but not to pericentric major satellite 
regions in iPS cells (Fig. 8, A and B). These results suggest that 
SIRT1 effects on telomere function and in length regulation 
may be mediated by binding of SIRT1 to telomeric repeats.
Discussion
The Sir2 family of nutrient-responsive NAD
+-dependent de-
acetylases has emerged as key regulator of lifespan in yeast and 
other organisms (Haigis and Guarente, 2006). CR studies have 
shown that SIRT1, the closest mammalian homologue of yeast 
Figure 7.  SIRT1-increased expression decreases histone acetylation at telomeric and centromeric chromatin. (A, C, E, and G) ChIP was performed with 
primary (passage 2) MEFs of the indicated genotypes (n = 3) using specific antibodies against H3, H3K9me3, H3K9Ac, H4K20me3, HP1-, and TRF1.   
Immunoprecipitated material was transferred to a nitrocellulose membrane and probed with a 1.6-kb telomeric probe (A and E) or probed with a mouse   
major satellite probe (C). (B, D, F, and H) Quantification of ChIP values for telomere and centromere repeats as indicated. The amount of immunoprecipi-
tated DNA was normalized for the amount of telomere or centromeric repeats present in the cross-linked chromatin fraction unbound to the preimmune 
serum (input). n = number of independent MEFs used. Bars represent the mean between replicates, and SEM is shown. A Student’s t test was used to 
calculate statistical significance, and p-values are shown.1309 Beneficial effects of increasing SIRT1 on telomere maintenance • Palacios et al.
better  maintenance  of  telomere  length  with  increasing  age 
(Pfluger et al., 2008; Herranz et al., 2010). Interestingly, both 
mean and maximum longevity are not increased in SIRT1
super 
mice in spite of increased health span (Herranz et al., 2010) and 
longer telomeres (this study), which goes in line with our recent 
observations that improved telomere maintenance increases 
longevity only when in highly cancer-resistant backgrounds 
(Tomás-Loba et al., 2008). Finally, these findings also open the 
interesting possibility that SIRT1-dependent effects of CR, or 
the beneficial effects of SIRT1 activators, could be partially me-
diated by SIRT1-positive effects on telomere length mainte-
nance, although this remains to be addressed.
In addition, SIRT1
super cells showed augmented frequen-
cies of sister chromatid homologous recombination events at 
telomeres, centromeres, and chromosome arms, indicating that 
SIRT1-increased expression significantly impacts homologous 
recombination. Interestingly, these results also suggest that in-
creased SIRT1 expression may positively impact DNA repair 
efficiency, thereby also contributing to increased tissue fitness 
and health span. In support of this, SIRT1 has been implicated   
in protection from DNA damage–induced cell death and carcino-
genesis (Oberdoerffer et al., 2008; Wang et al., 2008; Herranz   
et al., 2010). Finally, SIRT1 is likely to influence homologous 
recombination through deacetylation of Nbs1 and WRN heli-
case, two important players in DNA repair by homologous re-
combination (Yuan et al., 2007; Uhl et al., 2010).
In contrast with the effects of SIRT1 overexpression on 
telomere  length  maintenance  and  improved  homologous  re-
combination, we found that SIRT1 deficiency had a negative 
impact both on telomere length maintenance and telomere in-
tegrity, which is in agreement with recent data (El Ramy et al., 
2009). In particular, SIRT1
/ MEF showed an increase in chro-
mosomes with MTS, which are further increased by aphidicolin 
treatment, indicative of increased telomere fragility and break-
age. Accordingly, cells lacking SIRT1 showed a higher level of 
telomere damage (TIFs). Together, these findings suggest a role 
of SIRT1 on preventing telomere damage, which could again be 
mediated by some of its known deacetylation targets, including 
Nbs1 and WRN. Additionally, SIRT1-altered expression re-
sulted in changes in the heterochromatic status of telomeres, 
which go in line with a model where SIRT1 levels negatively 
modulate histone acetylation at telomeric chromatin, concomi-
tantly increasing heterochromatic marks such as H3K9me3   
and H4K20me3. Previous studies have shown that SIRT1 can 
deacetylate H3K9Ac and H4K16Ac (Vaquero et al., 2004;   
Vaquero et al., 2007), H3K56Ac (Chen et al., 2008; Das et al., 
2009), and H3K26Ac (Oberdoerffer et al., 2008) and as a   
consequence of decreased acetylation, can lead to higher abun-
dance of heterochromatic marks like H2K9me3 and H4K20me1   
(Vaquero et al., 2004). A SIRT1-dependent increase in H4K20me3 
has not been previously reported. However, SIRT1 can specifi-
cally target the histone methyltransferase suppressor of variega-
tion 3-9 homologue (Suv39h1), leading to increased H2K9me3 
(Vaquero et al., 2007), and therefore, H2K9me3 recruits HP1, 
which is necessary to assemble H4K20me3 at pericentric chro-
matin (Schotta et al., 2004). Importantly, we show in this study 
that SIRT1 can interact in vivo with telomeric repeats in the 
the mean lifespan of cancer-resistant mice by 40% (Tomás-
Loba et al., 2008).
In this study, we set out to address whether SIRT1 may 
have an impact on telomere length maintenance by studying 
both  loss  of  function  (SIRT1
/  mice)  and  gain  of  function 
mouse models for SIRT1 (SIRT1
super mice). The latter mouse 
model is particularly interesting for aging studies, as we re-
cently showed that SIRT1
super mice have an increased health 
span and are protected from metabolic syndrome and liver can-
cer associated with metabolic syndrome (Pfluger et al., 2008; 
Herranz et al., 2010). Furthermore, several SIRT1 direct and indi-
rect activators, including resveratrol, have been recently described 
to  have  beneficial  effects  on  several  age-associated  diseases 
(Baur et al., 2006; Lagouge et al., 2006; Milne et al., 2007; 
Feige et al., 2008; Pearson et al., 2008; Yamazaki et al., 2009).
In this study, we find that overexpression of SIRT1 in 
mice decreases the rate of telomere erosion associated with cell 
division and tissue aging (i.e., liver and kidney), whereas SIRT1 
abrogation results in an increased telomere erosion. The bene-
ficial effects of increased SIRT1 activity on telomere length 
maintenance occur without any detrimental effects on telomere 
integrity or telomere capping. Furthermore, we show that improved 
maintenance of telomeres in SIRT1
super cells is dependent on an 
active telomerase complex, suggesting that SIRT1-increased ex-
pression impacts the telomerase pathway. Interestingly, it has 
been previously described that silencing of SIRT1 by RNAi   
results in an increase of telomerase expression in HeLa cells 
(Narala et al., 2008). Our findings suggest that the increased 
health span of SIRT1
super mice may be due, at least in part, to a 
Figure 8.  SIRT1 protein interacts with telomeric repeats in vivo in iPS cells. 
(A) ChIP was performed with iPS cells of the indicated genotype (n = 3) 
using antibodies against SIRT1 and TRF1. Immunoprecipitated material 
was transferred to a nitrocellulose membrane and probed with a 1.6-kb 
telomeric probe (top) and a mouse major satellite (bottom). (B) Quantifi-
cation of ChIP values for telomere and centromere repeats as indicated. 
The amount of immunoprecipitated DNA was normalized for the amount 
of telomere or centromeric repeats present in the cross-linked chromatin 
fraction unbound to the preimmune serum (input). n = number of indepen-
dent MEFs used. Bars represent the mean between replicates, and SEM is 
shown. A Student’s t test was used to calculate statistical significance, and 
p-values are shown.JCB • VOLUME 191 • NUMBER 7 • 2010   1310
donkey anti–mouse (1:300; Jackson ImmunoResearch Laboratories, Inc.). 
Slides were washed in PBS with 0.1% Triton X-100 and mounted in Vecta-
shield  with  DAPI  (Vector  Laboratories).  Confocal  microscopy  was  per-
formed at room temperature with a laser-scanning microscope (TCS SP5; 
Leica) using a Plan Apo 63× 1.40 NA oil immersion objective (HCX; 
Leica). The pictures show the maximal projection of z stacks generated   
using advanced fluorescence software (LAS; Leica).
Telomere and fluorescence analyses on liver and kidney sections
Q-FISH was performed directly on liver and kidney sections as previously 
described (Zijlmans et al., 1997; Muñoz et al., 2005). Confocal micros-
copy was performed at room temperature with a laser-scanning micro-
scope (TCS SP5) using a Plan Apo 63× 1.40 NA oil immersion objective 
(HCX). The pictures show the maximal projection of z stacks generated   
using advanced fluorescence software (LAS). Images were analyzed with 
Definiens XD software package. The DAPI image was use to define the nu-
clear area, and the fluorescent PNA telomeric probe screen was used to 
detect single telomeric signal inside of each nuclei.
Telomere length and cytogenetic analysis using telomere  
Q-FISH on metaphases
We prepared metaphases and performed Q-FISH hybridization as previ-
ously described (Samper et al., 2000; Gonzalo et al., 2006). To correct 
for lamp intensity and alignment, images from fluorescent beads (Invitro-
gen) were analyzed in parallel using the TFL-Telo program (provided by   
P. Lansdorp, British Columbia Cancer Research Centre, Vancouver, British 
Columbia, Canada). Telomere fluorescence values were extrapolated from 
the telomere fluorescence of lymphoma cell lines LY-R (R cells) and LY-S   
(S cells) with known telomere lengths of 80 kb and 10 kb, respectively. We 
captured the images at room temperature using a charge-coupled device 
camera (FK7512; COHU) on a fluorescence microscope (DMRB; Leica) 
with a Plan Apo 100× 1.40 NA oil immersion objective (HCX; Leica) using 
Q-FISH software (Leica) in a linear acquisition mode to prevent the satura-
tion of fluorescence intensity. TFL-Telo software (Zijlmans et al., 1997) was 
used to quantify the fluorescence intensity of telomeres from at least 10–15 
metaphases for each data point. When indicated, primary MEFs were 
treated with 0.5 µM aphidicolin for 24 h. For analysis of chromosomal   
aberrations, metaphases were analyzed by superimposing the telomere   
image on the DAPI image using the TFL-Telo software.
TRF analysis
Cells were included in agarose plugs, and TRF analysis was performed as 
described previously (Blasco et al., 1997). Mean telomere length was calcu-
lated by densitometric analysis using ImageJ (National Institutes of Health). 
After building 2D representation of signal intensity of each lane, mean telo-
mere length was defined as the intersection point of intersection of the x axis 
and a line that divided the area below the curve in equal parts.
B1-SINE Cobra analysis for global DNA methylation
Global DNA methylation levels were determined using the B1-SINE Cobra 
method as previously described (Benetti et al., 2007a,b). Estimation of the 
fraction of methylated B1 elements for each genotype was performed using 
the following formula: ([molarity of 45-bp band]/2)/([molarity of 45-bp 
band] + [molarity of 100-bp band]).
Analysis of genomic subtelomeric DNA methylation
DNA methylation of subtelomeric genomic regions of chromosomes 1 and 
2 (q-arms) was performed by PCR analysis after bisulfite modification as 
described previously (Benetti et al., 2007a,b). To examine the methylation 
status of subtelomeric CpG islands, 17–55 colonies were automatically 
sequenced for each cell line. Bisulfite genomic sequencing primers used 
against subtelomeric regions in chromosomes 1 and 2 were 5-CACCTCTA-
ACCACTTAAACCTAACAA-3  and  5-GGGAGTGGAAGGAATTAGTAG-
GTT-3, which flank positions 197,042,227–197,042,569 of chromosome 1 
in  the  mouse  NCBI36  genome  assembly,  and  5-TTACCAATACCAC-
CATTCCTCCA-3 and 5-GAGAGTAGTTAATTAGATGAGGAATA-3, which 
flank positions 181,837,807–181,838,281 at chromosome 2 in the mouse 
NCBI36 genome assembly. Results were analyzed for DNA methylation 
analysis using BiQ Analyzer software (Applied Biosystems).
ChIP assay
ChIP assays were performed as previously described (García-Cao et al., 
2004). In brief, after cross-linking and sonication, chromatin from 4 × 10
6 
cells were used per each immunoprecipitation with Protein A/G Plus aga-
rose beads (sc-2003; Santa Cruz Biotechnology, Inc.) and the following 
antibodies: 6 µg anti–histone H3 (ab1791; Abcam), 6 µg anti–histone H4 
context of iPS cells, arguing that SIRT1 roles in regulation of 
telomere length, integrity, and recombination and telomere   
heterochromatin could be explained at least in part by a direct 
SIRT1 binding to telomeres in vivo.
In summary, the findings described in this study demon-
strate that increased expression of SIRT1, the closest mam-
malian orthologue of yeast Sir2, improves telomere length 
maintenance in vivo and significantly increases recombination 
frequencies at telomeres, centromeres, and chromosome arms. 
These  effects  of  increased  SIRT1  expression  are  potentially 
beneficial to preserve genome integrity and stability and open 
new  avenues  to  understand  the  known  effects  of  increased 





super  (C57BL/6  background)  and  SIRT1
/  (mixed  129/Sv  and 
C57BL/6 background) mice were provided by M. Serrano (Spanish Na-
tional Cancer Centre, Madrid, Spain; Pfluger et al., 2008) and F. Alt (Harvard 











super mice were crossed with Terc
/ (C57BL/6 back-
ground) animals (Blasco et al., 1997), and the resulting double-heterozygous 




+/+ mice. Mice were housed in a Specific Pathogen Free 
facility and treated according to the Federations of European Laboratory 
and Animal Science Association. All animals were maintained in a normal 
maintenance diet (2018; Harlan Laboratories).
Cell culture
Primary  MEFs  (passage  2)  were  obtained  from  SIRT1
+/+,  SIRT1











/ embryos as described previously (Blasco et al., 1997). To generate 
iPS cells, MEFs from the indicated genotypes were reprogrammed as de-
scribed previously (Marión et al., 2009a,b). SIRT1
+/+ and SIRT1
/ MEFs 
were transfected with pHA-SIRT1 (#10962; Addgene) or pCruz-HA (sc-5045; 
Santa Cruz Biotechnology, Inc.) plasmids using the Neon Transfection Sys-
tem (Invitrogen) according to the manufacturer’s conditions, and cells were 
harvested 4 d after transfection.
Telomerase assay
Telomerase activity was measured with a modified TRAP as previously de-
scribed (Blasco et al., 1997). Whole cell extracts were incubated with 
(UUAGGG)3 or (CCCUAA)3 RNA oligonucleotides for 5 min on ice and for 
5 min at room temperature before beginning the telomerase extension re-
action. To degrade spiked RNA oligonucleotides before PCR amplification, 
samples were treated with 10 pg RNase A (QIAGEN) at room temperature 
for 20 min.
Immunoblotting
Cells were harvested by trypsinization, washed once with PBS, lysed with 
cold RIPA, resuspended in SDS-PAGE loading buffer, and sonicated. Equal 
amounts of protein (50–100 mg) were analyzed by gel electrophoresis fol-
lowed by Western blotting. The following antibodies were used for immuno-
blotting: rabbit anti-SIRT1 (ab12913; Abcam), mouse anti-HA (sc-7392; 
Santa Cruz Biotechnology, Inc.), and anti–-tubulin (T6557; Sigma-Aldrich)   
as a loading control. Antibody binding was detected after incubation   
with a secondary antibody coupled to horseradish peroxidase using en-
hanced chemiluminescence.
Immunofluorescence
MEFs growing in coverslips were permeabilized by incubation in PBS with 
0.5% BSA and 0.1% Triton X-100 for 15 min. After permeabilization, 
slides were blocked in 2% BSA for 1 h and incubated with primary anti-
body. Permeabilized sections were incubated with rabbit anti-TRF1 (1:200) 
prepared as described previously (Muñoz et al., 2005), mouse monoclo-
nal anti-phospho–histone H2AX antibody (1:500; Millipore), and second-
ary antibodies Cy3-conjugated goat anti–rabbit (1:400) and Alexa Fluor 555 1311 Beneficial effects of increasing SIRT1 on telomere maintenance • Palacios et al.
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